Financials
Financial year 2024
ASSENTFARMA from Bekkevoort, company number BE0476449350, closed financial year 2024 with a result of € 136,937 after tax. For that financial year ASSENTFARMA recorded a gross margin of € 196,677 and equity of € 831,368. Compared with financial year 2023, the result moved from € 116,630 to € 136,937. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2025.
€ 831,368
▲ 10% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 136,937
▲ 17% vs 2023
Profit after tax over the fiscal year.
€ 357,650
▼ 22% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 60,000 paid out
44 % of the profit went to the shareholders, mostly to CLAVANTI (99 % of the shares). That is where the money ends up.
People and assets in 2024
0.3
▲ 0.2 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 14,083
▲ 30% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 948
▼ 62% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 76,646
▲ 7% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 4,284
▲ 22% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 214,608 | € 188,089 | € 169,657 | € 196,677 | ▲ 16% |
| Profit after taxes | € 175,529 | € 148,021 | € 116,630 | € 136,937 | ▲ 17% |
| Equity | € 614,780 | € 682,801 | € 754,431 | € 831,368 | ▲ 10% |
| Total debts | € 324,717 | € 265,661 | € 229,507 | € 250,377 | ▲ 9% |
| Cash | € 442,225 | € 431,677 | € 460,245 | € 357,650 | ▼ 22% |
| Retained profit | € 552,780 | € 620,801 | € 692,431 | € 769,368 | ▲ 11% |
| Dividend | € 125,000 | € 80,000 | € 45,000 | € 60,000 | ▲ 33% |
| Balance sheet total | € 939,497 | € 948,462 | € 983,938 | € 1,081,745 | ▲ 10% |
| Employees (FTE) | 0.9 | 0.1 | 0.1 | 0.3 | ▲ 0.2 |
Key figures of ASSENTFARMA, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to ASSENTFARMA?
What happened at ASSENTFARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 136,937 (▲ 17% vs 2023). Source: NBB ↗
- New establishment in Bekkevoort. KBO
- Start of the company according to the CBE. KBO
In short
From € 175,529 profit in 2021 to € 136,937 profit in 2024.
Paid € 91,775 in corporate taxes since 2021.
Best year ever: 2021, with € 175,529 profit.
Paid out € 310,000 in dividends to the owners in total.
A new publication or filing at ASSENTFARMA? We notify you, reason included.
Follow ASSENTFARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of CLAVANTI comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
ASSENTFARMABehind ASSENTFARMA is Clavanti BV. The shares are held by CLAVANTI (99%).
Directors
According to the 2024 annual accounts
Director · represented by Gustaaf Claesen
Shareholders
99%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Dorpsstraat 8
3460 Bekkevoort
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
AMAZON-02 - Amazon.com, Inc., US
DNS
AWS Route 53
Website info
Features
Security
Network
Details
- Company number
- 0476.449.350
- VAT number
- BE 0476.449.350
- Registered office
- Dorpsstraat 8, 3460 Bekkevoort
- Names & denominations
- ASSENTFARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 4 January 2002
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- apotheekassentfarma.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers